dofetilide
Selected indexed studies
- Cardiovascular drugs. Dofetilide. (Circulation, 2000) [PMID:11085972]
- Dofetilide versus quinidine for atrial flutter: viva la difference!? (J Cardiovasc Electrophysiol, 1996) [PMID:8884511]
- Dofetilide: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias. (Card Electrophysiol Clin, 2016) [PMID:27261832]
_Worker-drafted node — pending editorial review._
Connections
dofetilide is a side effect of
Sources
- Cardiovascular drugs. Dofetilide. (2000) pubmed
- Dofetilide versus quinidine for atrial flutter: viva la difference!? (1996) pubmed
- Dofetilide: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias. (2016) pubmed
- Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: A case series and literature review. (2018) pubmed
- Dofetilide: a review of its use in atrial fibrillation and atrial flutter. (1999) pubmed
- MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia. (2022) pubmed
- Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure. (2000) pubmed
- Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies. (2014) pubmed
- Dofetilide (Tikosyn): a new drug to control atrial fibrillation. (2001) pubmed
- Dofetilide: a class III-specific antiarrhythmic agent. (2000) pubmed